||November

ARTIFICIAL VISION : Pixium Vision: First Clinical Results and Innovative Developments

Pixium Vision and its partners are developing two VRS solutions for blind patients: an epi-retinal and a sub-retinal approach. This chapter describes the specificities of the epi-retinal IRIS® VRS that has obtained the European CE mark cerfication, and also discuss the associatedinnovations developed at the Vision Institute for future VRS models. Read more »

2019-09-11T17:32:32+02:00November 25th, 2016|Publications|